Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Kynurenine: an oncometabolite in colon cancer.

Venkateswaran N, Conacci-Sorrell M.

Cell Stress. 2020 Jan 3;4(1):24-26. doi: 10.15698/cst2020.01.210.

2.

Induction of LEF1 by MYC activates the WNT pathway and maintains cell proliferation.

Hao YH, Lafita-Navarro MC, Zacharias L, Borenstein-Auerbach N, Kim M, Barnes S, Kim J, Shay J, DeBerardinis RJ, Conacci-Sorrell M.

Cell Commun Signal. 2019 Oct 17;17(1):129. doi: 10.1186/s12964-019-0444-1.

3.

MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancer.

Venkateswaran N, Lafita-Navarro MC, Hao YH, Kilgore JA, Perez-Castro L, Braverman J, Borenstein-Auerbach N, Kim M, Lesner NP, Mishra P, Brabletz T, Shay JW, DeBerardinis RJ, Williams NS, Yilmaz OH, Conacci-Sorrell M.

Genes Dev. 2019 Sep 1;33(17-18):1236-1251. doi: 10.1101/gad.327056.119. Epub 2019 Aug 15.

4.

Identification of Calpain-Activated Protein Functions.

Del Carmen Lafita-Navarro M, Conacci-Sorrell M.

Methods Mol Biol. 2019;1915:149-160. doi: 10.1007/978-1-4939-8988-1_12.

PMID:
30617802
5.

The aryl hydrocarbon receptor regulates nucleolar activity and protein synthesis in MYC-expressing cells.

Lafita-Navarro MC, Kim M, Borenstein-Auerbach N, Venkateswaran N, Hao YH, Ray R, Brabletz T, Scaglioni PP, Shay JW, Conacci-Sorrell M.

Genes Dev. 2018 Oct 1;32(19-20):1303-1308. doi: 10.1101/gad.313007.118. Epub 2018 Sep 25.

6.

Competition between TIAM1 and Membranes Balances Endophilin A3 Activity in Cancer Metastasis.

Poudel KR, Roh-Johnson M, Su A, Ho T, Mathsyaraja H, Anderson S, Grady WM, Moens CB, Conacci-Sorrell M, Eisenman RN, Bai J.

Dev Cell. 2018 Jun 18;45(6):738-752.e6. doi: 10.1016/j.devcel.2018.05.021.

7.

MYC leads the way.

Venkateswaran N, Conacci-Sorrell M.

Small GTPases. 2017 Nov 25:1-9. doi: 10.1080/21541248.2017.1364821. [Epub ahead of print]

PMID:
29173017
8.

MYC-nick promotes cell migration by inducing fascin expression and Cdc42 activation.

Anderson S, Poudel KR, Roh-Johnson M, Brabletz T, Yu M, Borenstein-Auerbach N, Grady WN, Bai J, Moens CB, Eisenman RN, Conacci-Sorrell M.

Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):E5481-90. doi: 10.1073/pnas.1610994113. Epub 2016 Aug 26.

9.

PIAS1 Promotes Lymphomagenesis through MYC Upregulation.

Rabellino A, Melegari M, Tompkins VS, Chen W, Van Ness BG, Teruya-Feldstein J, Conacci-Sorrell M, Janz S, Scaglioni PP.

Cell Rep. 2016 Jun 7;15(10):2266-2278. doi: 10.1016/j.celrep.2016.05.015. Epub 2016 May 26.

10.

Stress-induced cleavage of Myc promotes cancer cell survival.

Conacci-Sorrell M, Ngouenet C, Anderson S, Brabletz T, Eisenman RN.

Genes Dev. 2014 Apr 1;28(7):689-707. doi: 10.1101/gad.231894.113.

11.

An overview of MYC and its interactome.

Conacci-Sorrell M, McFerrin L, Eisenman RN.

Cold Spring Harb Perspect Med. 2014 Jan 1;4(1):a014357. doi: 10.1101/cshperspect.a014357. Review. Erratum in: Cold Spring Harb Perspect Med. 2014 Apr;4(4). doi:10.1101/cshperspect.a023325.

12.

Dual regulation of Myc by Abl.

Sanchez-Arévalo Lobo VJ, Doni M, Verrecchia A, Sanulli S, Fagà G, Piontini A, Bianchi M, Conacci-Sorrell M, Mazzarol G, Peg V, Losa JH, Ronchi P, Ponzoni M, Eisenman RN, Doglioni C, Amati B.

Oncogene. 2013 Nov 7;32(45):5261-71. doi: 10.1038/onc.2012.621. Epub 2013 Jan 14.

13.

Premetazoan ancestry of the Myc-Max network.

Young SL, Diolaiti D, Conacci-Sorrell M, Ruiz-Trillo I, Eisenman RN, King N.

Mol Biol Evol. 2011 Oct;28(10):2961-71. doi: 10.1093/molbev/msr132. Epub 2011 May 13.

14.

Post-translational control of Myc function during differentiation.

Conacci-Sorrell M, Eisenman RN.

Cell Cycle. 2011 Feb 15;10(4):604-10. Epub 2011 Feb 15.

15.

Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiation.

Conacci-Sorrell M, Ngouenet C, Eisenman RN.

Cell. 2010 Aug 6;142(3):480-93. doi: 10.1016/j.cell.2010.06.037.

16.

The shed ectodomain of Nr-CAM stimulates cell proliferation and motility, and confers cell transformation.

Conacci-Sorrell M, Kaplan A, Raveh S, Gavert N, Sakurai T, Ben-Ze'ev A.

Cancer Res. 2005 Dec 15;65(24):11605-12.

17.

L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers.

Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T, Ben-Ze'ev A.

J Cell Biol. 2005 Feb 14;168(4):633-42.

18.

Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK.

Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A.

J Cell Biol. 2003 Nov 24;163(4):847-57. Epub 2003 Nov 17.

19.

SKI activates Wnt/beta-catenin signaling in human melanoma.

Chen D, Xu W, Bales E, Colmenares C, Conacci-Sorrell M, Ishii S, Stavnezer E, Campisi J, Fisher DE, Ben-Ze'ev A, Medrano EE.

Cancer Res. 2003 Oct 15;63(20):6626-34.

20.

Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.

Conacci-Sorrell ME, Ben-Yedidia T, Shtutman M, Feinstein E, Einat P, Ben-Ze'ev A.

Genes Dev. 2002 Aug 15;16(16):2058-72.

21.

Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells.

Sadot E, Conacci-Sorrell M, Zhurinsky J, Shnizer D, Lando Z, Zharhary D, Kam Z, Ben-Ze'ev A, Geiger B.

J Cell Sci. 2002 Jul 1;115(Pt 13):2771-80.

22.

The cadherin-catenin adhesion system in signaling and cancer.

Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A.

J Clin Invest. 2002 Apr;109(8):987-91. Review. No abstract available.

Supplemental Content

Loading ...
Support Center